CD274 and neoplasm: The immune-based approach relies on the observation that tumor cells can survive by escaping the immune system when they express, on their surface membrane, the programmed cell death ligand 1 (PDL-1), which is able to bind the programmed death-1 (PD-1) receptor on activated T cells.